Who owns Anteris Technologies Global Corp. (AV)? Elite investor 13F holders
2 tracked elite investors reported holding Anteris Technologies Global Corp as of 2026-06-30, including Oasis Management, Renaissance Technologies LLC. Who bought, trimmed or exited each quarter, with links to the original SEC 13F filings.
2 tracked investors currently reported holding · Latest report period: 2026-06-30 · Health Care · Health Care Equipment & Services
Anteris Technologies Global Corp., a structural heart company, develops and commercializes minimally invasive medical devices to treat heart valve diseases. It offers the DurAVR transcatheter heart valve system, a novel transcatheter aortic valve for the treatment of severe aortic stenosis that is shaped to mimic the performance of a healthy human aortic valve. The company also develops ADAPT…
Reported holders and securities, including exits (up to 20)
| Investor | Security | Instrument | Report period | Filed | Value | Quantity | Units | Change | Source |
|---|---|---|---|---|---|---|---|---|---|
| Oasis Management | ANTERIS TECHNOLOGIES GLOBAL | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 180285.00 USD | 18303.000000 | Shares | reduce | Original filing |
| Renaissance Technologies LLC | ANTERIS TECHNOLOGIES GLOBAL | SHARE | 2026-06-30 | 2026-08-13 00:00:00 | 3472125.00 USD | 352500.000000 | Shares | buy | Original filing |
Public disclosures can be delayed, incomplete, or amended. Report period describes a position date; transaction date describes a reported transaction; filed describes submission. A recent filing or page update does not establish a current holding. A dash means unavailable or not comparable, not zero.
This public summary shows the default reporting scope. Enable JavaScript for interactive filters, charts, and additional rows.